AzTrials
AzTrials

Eating DisordersPhase 1NCT00870753

Yoga in Treatment of Eating Disorders

A Phase 1 study testing Yoga in people with Eating Disorders, run by Norwegian School of Sport Sciences at 1 site in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Purpose: to examine effects of hatha yoga in treatment of eating disorders. Methods: Participants: patients with DSM-IV Anorexia Nervosa, Bulimia Nervosa or Eating Disorders Not Otherwise Specified will be invited to participate in this study. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Eating Disorders
What is being tested?
Yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteNorway
Study dates
Mar 2009to Dec 2011
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 18 or above
  • DSM-IV Anorexia nervosa, Bulimia nervosa or Eating disorders not otherwise specified

Who cannot join

  • serious medical complications
  • psychosis
  • suicidal behavior

Trial locations and contacts

1 site in 1 country.

Kari E Karlsen, psych student contact

k.e.karlsen@psykologi.uio.no

Solfrid Bratland-Sanda, master sports science contact

solfrid.bratland-sanda@nih.no

Norway1 site, 1 recruiting
  • Norwegian School of Sport Sciences

    Oslo, Oslo, 0806

    Kari E Karlsen, psych student

    Jorunn Sundgot-Borgen, PhD

    Recruiting

Other trials in Norway

About this study

Purpose: to examine effects of hatha yoga in treatment of eating disorders.

Methods:

Participants: patients with DSM-IV Anorexia Nervosa, Bulimia Nervosa or Eating Disorders Not Otherwise Specified will be invited to participate in this study. Exclusion criteria will be age under 18, serious medical complications, psychosis or increased risk of suicide.

Design: randomized controlled single-blinded trial. Intervention: 2 x 90 min weekly group sessions for 12 weeks with hatha yoga. Main outcome measure: reduction in Eating Disorders Examination score. Secondary outcome measures: reduction in body dissatisfaction, depression and anxiety

Read the detailed description

For the last years, yoga has become a popular "body-mind" form of exercise in western countries (Daubenmier, 2005). Yoga has shown good effects on increasing muscle strength, flexibility and stability, in addition studies have found reduced stress level, improved mood and breathing (Astin et al., 2003; Gimbel, 1998b; Granath et al., 2006; Lavey et al., 2005; Manjunatha et al., 2005b; Netz \& Lidor, 2003a; Telles \& Naveen, 1997b; Yadav et al., 2005b). Previous research have shown a tendency for persons practicing yoga improving body awareness and body sensitivity, and reduction of body dissatisfaction (Daubenmier, 2005). In addition, two studies have examined yoga in treatment of binge eating disorder (Daubenmier, 2005; Gimbel, 1998a). Results showed reduction in number of binge eating episodes in the intervention group compared to the control group. No available studies have examined effect of yoga in treatment of the eating disorders types Anorexia Nervosa or Bulimia Nervosa.

Being tested
Yoga
Keywords
Eating disorders, yoga, body awareness, depression, anxiety
Medical subject headings
Feeding and Eating Disorders, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • YogaBehavioural

    90 min hatha yoga 2 times per week for 12 weeks.

Study groups in NCT00870753
Study groupRoleWhat they receive
YogaExperimental90 min hatha yoga 2 times per week for 12 weeks.
Receives: Behavioral: Yoga
ControlsNo interventionControl group are offered the yoga intervention after finishing the study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. reduction in eating disorders symptoms assessed by Eating Disorders Examination clinical interview

    Measured: after 12 weeks

Secondary outcomes (1)
  1. increased body awareness

    Measured: after 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2009 (estimated)
  2. Study startMar 2009
  3. Primary completionDec 2010 (estimated)
  4. Study completionDec 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00870753
Sponsor's protocol ID
2.2006.1243
Status last verified
Mar 2009
First submitted
26 Mar 2009
Last updated
27 Mar 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Yoga in people with Eating Disorders, run by Norwegian School of Sport Sciences at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Mar 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kari E Karlsen, psych student (k.e.karlsen@psykologi.uio.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

reduction in eating disorders symptoms assessed by Eating Disorders Examination clinical interview (time frame: after 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in